EUVIMEDEUVIMED entdecken
Crossref

Immunogenicity of Double-Stranded RNA in mRNA Vaccines and its Impact on Immune Cell Function 2335037

Christopher Lopez, Seyedehmahsa Moghimi, Ethan McCurdy, Cheng Hui Hu, Tanveer Sandhu, Aashiq Mirza, Joanna Varughese, Patty Gu, Ashley Gelbard, Urmi Patel, Lei Hu, Mindy Wang und 14 weitere

The Journal of Immunology · 01.08.2026 · 215 (Supplement_1)

DOI: 10.1093/jimmun/vkag141.1872 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Immunology, online erschienen am 28.07.2026. Verfasst von Christopher Lopez und 25 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Double-stranded RNA (dsRNA) is a natural activator of innate immune responses in mammalian cells and can form as a limited byproduct during in vitro transcription of mRNA vaccines Methods We sought to further characterize humoral and cell-mediated immune responses to varying levels of dsRNA using a prototype nucleoside-modified mRNA (modRNA) based respiratory syncytial virus (RSV) vaccine. The modRNA lipid nanoparticle formulations contained defined quantities of a full-length dsRNA generated from complementary sense and antisense strands of RSV modRNA.

Results

In vivo analysis in BALB/c mice revealed that increasing levels of dsRNA impurities in a modRNA LNP vaccine delivered intramuscularly led to a modest induction of inflammatory cytokines, including Type I interferons, but had no effect on neutralizing antibody titers or the functionality of CD4+ and CD8+ T cells. In parallel, in vitro analysis of human PBMCs exposed to the same formulations showed no significant changes in inflammatory cytokine production or cell-mediated immunity; Increasing levels of dsRNA impurities did not alter population composition, antigen-presenting cell (APC) activation, or CD4+ and CD8+ T cell exhaustion, indicating limited immunostimulatory potential of N1-Methylpseudouridine (m1ψ) modified dsRNA in immune cells.

Conclusion

Together, these results improve our understanding of potential dsRNA impurities and immune responses in mRNA vaccines. Funding Source n/a Topic Categories Vaccines and Immunotherapy (VAC)

Zitieren

APA

Lopez, C., Moghimi, S., McCurdy, E., Hu, C. H., Sandhu, T., Mirza, A., Varughese, J., Gu, P., Gelbard, A., Patel, U., Hu, L., Wang, M., Chipley, M., Paul, A., Patel, A., Kong, F., Singh, R., Malde, D., Chen, W., …, & Efferen, K. (2026). Immunogenicity of Double-Stranded RNA in mRNA Vaccines and its Impact on Immune Cell Function 2335037. The Journal of Immunology, 215(Supplement_1). https://doi.org/10.1093/jimmun/vkag141.1872

Vancouver

Lopez C, Moghimi S, McCurdy E, Hu CH, Sandhu T, Mirza A, et al. Immunogenicity of Double-Stranded RNA in mRNA Vaccines and its Impact on Immune Cell Function 2335037. The Journal of Immunology. 2026;215(Supplement_1). doi:10.1093/jimmun/vkag141.1872

BibTeX
@article{Lopez2026,
  author = {Lopez, Christopher and Moghimi, Seyedehmahsa and McCurdy, Ethan and Hu, Cheng Hui and Sandhu, Tanveer and Mirza, Aashiq and Varughese, Joanna and Gu, Patty and Gelbard, Ashley and Patel, Urmi and Hu, Lei and Wang, Mindy and Chipley, Mark and Paul, Aparna and Patel, Arkee and Kong, Fanrong and Singh, Raymond and Malde, Darshan and Chen, Wei and Tompkins, Kristin and Daroca, Pilar Mendoza and Huang, Bridget and Swanson, Kena and Giannakou, Andreas and Meng, Fanyu and Efferen, Kari},
  title = {Immunogenicity of Double-Stranded RNA in mRNA Vaccines and its Impact on Immune Cell Function 2335037},
  journal = {The Journal of Immunology},
  year = {2026},
  volume = {215},
  number = {Supplement_1},
  doi = {10.1093/jimmun/vkag141.1872}
}
Kostenlos starten →